The immunosuppressive activity of tumor-infiltrating MDSCs was reversed when mice were treated with L-NIL, a selective iNOS inhibitor, demonstrating an iNOS-dependent VEGF secretory pathway necessary for MDSC recruitment [75]. Here, NOS2 is linked to neoplasm.